We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App





New AI-Powered Diagnostic Solution Accelerates COVID-19 Screening

By HospiMedica International staff writers
Posted on 22 Jun 2020
A robust AI-powered solution that uses advanced deep learning models to sort and identify chest X-rays of patients with COVID-19 can enable healthcare professionals to accelerate the screening of COVID-19 patients with pneumonia symptoms.

The AI-powered diagnostic solution developed by QuEST Global (Singapore) has an accuracy of more than 95%, allowing it be deployed on the cloud as a service, thus making it easily accessible on edge for healthcare professionals and end-users. More...
The solution is backed by Microsoft Azure Machine Learning, which helps accelerate the development and deployment on machine learning models in a highly secure and trusted fashion.

QuEST developed the technology demonstrator using chest X-rays of healthy individuals, patients with symptoms of pneumonia and COVID-19. These X-rays were used to train and build a deep neural network model that could discriminate the radiological patterns of pneumonia related to COVID-19 and highlight the suspicious ones, thus leading to a faster screening of the disease.

“As the pandemic continues to rage, our focus has been to deliver a solution that can support the healthcare professionals effectively,” said Krish Kupathil, Global Head, Hi-Tech and Digital, QuEST Global. “Since the fight against COVID-19 is all about faster screening and immediate isolation of maximum number of people, we aim to accelerate the screening time as much as possible. The AI-based solution will make radiography examinations much faster by leveraging modern image diagnostic systems. As we continue to add more features, we aim to reduce the screening time to less than a minute.”

“In these unprecedented times, saving human lives is the ultimate goal, and technology can help. Microsoft's collaborations with product engineering leaders like QuEST can go a long way to driving a more positive outcome,” said Michael Kuptz, General Manager, Americas IoT & Mixed Reality Sales, Microsoft. “For example, QuEST's AI-driven diagnostic solution, built on Microsoft Azure, empowers healthcare personnel in the fight against COVID-19 by reducing screening time, thereby enabling more testing capacity.”

Related Links:
QuEST Global


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
OR Table Accessory
Angular Accessory Rail
Premium Air-Mattress
MA-51
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.